Alpha-1 antitrypsin deficiency (AATD) is an autosomal recessive disorder caused by mutations in the SERPINA1 gene, which encodes the 52-kD plasma glycoprotein alpha-1 antitrypsin (AAT), the main in-hibitor of serine proteases released by neutrophils at inflammatory sites. Missense mutations of SERPINA1 often result in conformationally altered AAT variants with a variable tendency to form intracellular poly-mers in hepatocytes, predisposing to liver disease and the consequent secretory deficiency. In addition to the most common pathogenic variant Z (Glu342Lys), which accumulates as ordered aggregates in the en-doplasmic reticulum (ER) of hepatocytes, many other rare genetic variants have been identified in both patients and the general population by genetic screening. We have investigated a panel of 17 new AAT variants found in Italian patients in order to define their pathogenic risk and to identify new functionally crucial regions of the AAT molecule. We first used bioinformatics tools to predict the functional effects of the missense mutations and to select the likely pathogenic ones to be characterized in mammalian cell models. Polymers formation was evaluated by the tendency of the variants to accumulate as intracellular insoluble aggregates and by immunofluorescence staining, while secretion deficiency was analyzed by quantifying AAT in the culture media. Our results identified two severe AAT mutants with a Z-like profile and three milder variants. Another AAT variant revealed an atypical polymeric pattern that is currently being investigated. The overall behavior of the variants was in agreement with the pathogenicity scores of the REVEL predictor, supporting the utility of this bioinformatic tool in the initial assessment of newly identified amino acid substitutions of AAT. However, molecular and cellular characterization is required to better define the mutant-specific pathogenetic mechanisms in AATD patients with rare genotypes.

Molecular characterization of new variants associated with alpha-1-antitrypsin deficiency (AATD)

Giulia Bartoli;A. Fra
2022-01-01

Abstract

Alpha-1 antitrypsin deficiency (AATD) is an autosomal recessive disorder caused by mutations in the SERPINA1 gene, which encodes the 52-kD plasma glycoprotein alpha-1 antitrypsin (AAT), the main in-hibitor of serine proteases released by neutrophils at inflammatory sites. Missense mutations of SERPINA1 often result in conformationally altered AAT variants with a variable tendency to form intracellular poly-mers in hepatocytes, predisposing to liver disease and the consequent secretory deficiency. In addition to the most common pathogenic variant Z (Glu342Lys), which accumulates as ordered aggregates in the en-doplasmic reticulum (ER) of hepatocytes, many other rare genetic variants have been identified in both patients and the general population by genetic screening. We have investigated a panel of 17 new AAT variants found in Italian patients in order to define their pathogenic risk and to identify new functionally crucial regions of the AAT molecule. We first used bioinformatics tools to predict the functional effects of the missense mutations and to select the likely pathogenic ones to be characterized in mammalian cell models. Polymers formation was evaluated by the tendency of the variants to accumulate as intracellular insoluble aggregates and by immunofluorescence staining, while secretion deficiency was analyzed by quantifying AAT in the culture media. Our results identified two severe AAT mutants with a Z-like profile and three milder variants. Another AAT variant revealed an atypical polymeric pattern that is currently being investigated. The overall behavior of the variants was in agreement with the pathogenicity scores of the REVEL predictor, supporting the utility of this bioinformatic tool in the initial assessment of newly identified amino acid substitutions of AAT. However, molecular and cellular characterization is required to better define the mutant-specific pathogenetic mechanisms in AATD patients with rare genotypes.
2022
File in questo prodotto:
File Dimensione Formato  
ABSTRACT_ABCD_Bartoli et al.pdf

solo utenti autorizzati

Descrizione: Abstract a convegno
Tipologia: Abstract
Licenza: DRM non definito
Dimensione 228.03 kB
Formato Adobe PDF
228.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/555995
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact